APOC3 and hypertriglyceridemia: Kinetics studies in human subjects have shown that increased production rate of apoCIII rather than decreased apoCIII fractional catabolic rate is a determinant of the elevated plasma apoCIII levels that characterize patients with hypertriglyceridemia and features of insulin resistance[33], consistent with the effect of insulin resistance on the apoCIII promoter.